HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $2.61 per share for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2023-11-07
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $2.61, a 55.91% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-03-31 was $5.92, a 28.42% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-03-31 was $4.61, a 290.68% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-06-30 was $1.21, a 24.74% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $1.21, a 13.57% decline from fiscal 2019.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $1.40, a 23.50% decline from fiscal 2018.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $1.83, a 43.52% decline from fiscal 2017.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $3.24, a 4.52% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $2.61 10-Q · filed 2023-11-07 | ||||
| 2023-06-30 | $2.61 10-Q · filed 2023-08-08 | ||||
| 2023-03-31 | $2.61 10-Q · filed 2023-04-26 | ||||
| 2022-09-30 | $5.38 10-Q · filed 2022-11-09 | ||||
| 2022-03-31 | $5.92 10-Q · filed 2022-08-04 | ||||
| 2021-09-30 | $4.61 10-Q · filed 2021-11-05 | ||||
| 2021-06-30 | $4.61 10-Q · filed 2021-08-06 | ||||
| 2021-03-31 | $4.61 10-Q · filed 2021-05-07 | ||||
| 2020-12-31 | $1.21 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $1.21 10-Q · filed 2020-11-06 | ||||
| 2020-06-30 | $1.21 10-Q · filed 2020-08-10 | $1.21 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | $1.18 10-Q · filed 2020-05-08 | ||||
| 2019-12-31 | $1.40 10-K/A · filed 2021-03-17 | ||||
| 2019-09-30 | $1.21 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | $0.97 10-Q · filed 2020-08-10 | $1.56 10-Q · filed 2020-08-10 | $3.73 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $3.80 10-Q · filed 2019-05-08 | ||||
| 2018-12-31 | $1.83 10-K · filed 2020-03-16 | ||||
| 2017-12-31 | $3.24 10-K · filed 2018-03-16 | ||||
| 2016-12-31 | $3.10 10-K · filed 2018-03-16 | ||||
| 2016-06-30 | $3.24 10-Q · filed 2016-08-04 | ||||
| 2016-03-31 | $2.87 10-Q · filed 2016-05-16 | ||||
| 2015-12-31 | $5.31 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $5.51 10-Q · filed 2015-11-05 | ||||
| 2015-06-30 | $5.51 10-Q · filed 2015-08-06 | ||||
| 2015-03-31 | $5.51 10-Q · filed 2015-05-07 | ||||
| 2014-12-31 | $4.18 10-K · filed 2017-03-17 | ||||
| 2014-09-30 | $4.14 10-Q · filed 2014-11-06 | ||||
| 2014-06-30 | $4.13 10-Q · filed 2014-08-07 | ||||
| 2014-03-31 | $4.61 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | $4.44 10-K · filed 2016-04-29 | ||||
| 2013-09-30 | $2.64 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $2.64 10-Q · filed 2013-08-09 | ||||
| 2013-03-31 | $2.14 10-Q · filed 2013-05-10 | ||||
| 2012-12-31 | $3.60 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $1.84 10-Q · filed 2012-11-08 | ||||
| 2012-06-30 | $1.84 10-Q · filed 2012-08-09 | ||||
| 2011-12-31 | $5.64 10-K · filed 2014-03-14 | ||||
| 2010-12-31 | $3.61 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |